Trastuzumab deruxtecan plus pertuzumab showed significant improvement in PFS compared with taxane chemotherapy plus ...

New data shed light on the best strategies for managing patients who develop interstitial lung disease while being treated ...

Mumbai: The Bombay High Court has held that a civil suit cannot be filed merely on the basis of an apprehension that legal action might be initiated in the future.

I maintain a Buy rating on Zymeworks Inc. stock due to platform promise and upcoming catalysts. However, click for why I am ...

ASCO 2025 delivered pivotal updates. In this article, we discuss 8 of the more interesting abstracts from an investment ...

Petition in Karnataka HC asks Govt to invoke compulsory licensing clause that grants someone other than the patent holder the ...

George A. Roche, former chairman and president of T. Rowe Price, has always been on the quieter side. But ask him about almost anything, and he’ll give you his full-pronged analysis. Asked about ...

“Trastuzumab deruxtecan ... Novartis, Pfizer, and Roche. Richard Mark Kirkner is a medical journalist based in Philadelphia.

To receive the full newsletter in your inbox for free sign up here.) Adding Roche's (ROG.S), opens new tab immunotherapy drug Tecentriq to chemotherapy after surgery in certain patients whose ...

Bayer’s Vividion Therapeutics has secured the global rights from its partner Roche to the only covalent Werner helicase (WRN) inhibitor to have made it into the clinic. Vividion and Roche have ...